Related Experiment Videos
Kaposi's sarcoma, vascular permeability, and scientific integrity
1Department of Surgery, University of Arizona College of Medicine, Tucson 85724.
JAMA
|June 8, 1994
Summary
Replication of Nakamura et al.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Nakamura et al. reported sulfated polysaccharide peptidoglycan (SP-PG) inhibited Kaposi's sarcoma (KS)-related cells and lesions.
- The study focused on SP-PG's effects on KS growth and vascular hyperpermeability in nude mice.
Discussion:
- This study re-examined key findings from Nakamura et al. by analyzing composite figures and experimental data.
- Irregularities in the original publication's figures and data led to further investigation.
- Concerns regarding the reproducibility of pivotal findings were raised with the journal Science.
Key Insights:
- Independent experiments failed to confirm critical results reported by Nakamura et al.
- Analysis revealed photographic and data irregularities in the original publication's figures.
- The journal Science rejected initial correspondence regarding these concerns, prompting further investigation.
Outlook:
- The validity of Nakamura et al.'s conclusions remains questionable.
- The study raises concerns about the scientific peer-review process and self-correction in scientific research.
- Further investigation is needed to clarify the effects of SP-PG on Kaposi's sarcoma.